Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,464,852
  • Shares Outstanding, K 56,325
  • Annual Sales, $ 2,162 M
  • Annual Income, $ 523,370 K
  • 60-Month Beta 1.08
  • Price/Sales 4.07
  • Price/Cash Flow 10.08
  • Price/Book 2.64
Trade JAZZ with:

Options Overview

Details
  • Implied Volatility 42.89%
  • Historical Volatility 52.26%
  • IV Percentile 40%
  • IV Rank 15.38%
  • IV High 102.61% on 03/16/20
  • IV Low 32.04% on 02/12/21
  • Put/Call Vol Ratio 0.79
  • Today's Volume 3,770
  • Volume Avg (30-Day) 1,468
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 13,967
  • Open Int (30-Day) 9,843

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +1,998,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.01 +15.09%
on 02/03/21
178.64 -5.93%
on 02/24/21
+1.99 (+1.20%)
since 01/26/21
3-Month
140.00 +20.03%
on 11/30/20
178.64 -5.93%
on 02/24/21
+26.21 (+18.48%)
since 11/25/20
52-Week
86.88 +93.42%
on 03/23/20
178.64 -5.93%
on 02/24/21
+51.45 (+44.13%)
since 02/26/20

Most Recent Stories

More News
Jazz Pharma (JAZZ) Q4 Earnings Miss, 2021 Sales View Dull

Jazz Pharmaceuticals (JAZZ) reports mixed fourth-quarter 2020 results as earnings miss estimates while sales beat the same. Shares down.

JAZZ : 168.04 (-1.58%)
USNA : 97.06 (+0.65%)
GWPH : 214.25 (-0.28%)
SAVA : 48.58 (-4.52%)
Jazz: 4Q Earnings Snapshot

DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported fourth-quarter profit of $133.4 million.

JAZZ : 168.04 (-1.58%)
Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare Conference

, /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Cowen 41st Annual Healthcare conference.

JAZZ : 168.04 (-1.58%)
Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2020 Financial Results

, Feb. 23, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2020 and provided financial guidance for 2021.

JAZZ : 168.04 (-1.58%)
Jazz Pharmaceuticals Plc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 23, 2021 / Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23, 2021...

JAZZ : 168.04 (-1.58%)
Drug/Biotech Stock Q4 Earnings on Feb 23: JAZZ, ARNA & More

Let us take a look at five small biotech companies, JAZZ, ARNA, HALO, EPZM, ESPR, which are gearing up for their earnings release.

ARNA : 80.35 (+1.08%)
JAZZ : 168.04 (-1.58%)
HALO : 45.25 (-4.35%)
ESPR : 27.39 (-1.05%)
EPZM : 9.59 (-0.72%)
Should You Invest in Marijuana Stocks & ETFs Now?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

JAZZ : 168.04 (-1.58%)
GWPH : 214.25 (-0.28%)
CGC : 32.75 (-1.39%)
APHA : 17.84 (-2.09%)
MJ : 22.56 (-1.27%)
TLRY : 24.36 (-0.57%)
YOLO : 25.09 (+0.20%)
VFF : 15.79 (+4.09%)
THCX : 19.77 (-1.98%)
POTX : 16.53 (-2.99%)
TOKE : 20.40 (-2.16%)
CNBS : 30.12 (-2.02%)
Jazz Pharmaceuticals Announces Participation in the Leerink 10th Annual Global Healthcare Conference

, /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Leerink 10 Annual Global Healthcare Conference.

JAZZ : 168.04 (-1.58%)
Jazz Pharmaceuticals Completes Submission of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia

, /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration...

JAZZ : 168.04 (-1.58%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GW Pharmaceuticals plc - GWPH

, /PRNewswire/ -- , founder and managing partner at , a national securities firm rated in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in...

JAZZ : 168.04 (-1.58%)
GWPH : 214.25 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

3rd Resistance Point 175.86
2nd Resistance Point 173.87
1st Resistance Point 170.95
Last Price 168.04
1st Support Level 166.04
2nd Support Level 164.05
3rd Support Level 161.13

See More

52-Week High 178.64
Last Price 168.04
Fibonacci 61.8% 143.59
Fibonacci 50% 132.76
Fibonacci 38.2% 121.93
52-Week Low 86.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar